Basic | |
---|---|
Market Cap | $400.08M |
Price | $2.99 |
52 Week Range | 0.6001-3.59 |
Beta | -0.04 |
Margins | |
Gross Profit Margin | 85.26% |
Operating Profit Margin | 48.97% |
Net Profit Margin | 40.30% |
Valuation (TTM) | |
P/E Ratio | 1.78 |
Price to Sales Ratio | 0.79 |
Price to Book Ratio | 0.18 |
PEG Ratio | 0.02 |
Medical - Diagnostics & Research
Healthcare
1,202
2007-01-25T00:00:00.000Z
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
852 3605 8180
Bank of China Tower, Central, HK
0001467808